1.       Adams GGW, Bunce C, Xing W, et al.Treatment trends for reti nopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open 2017;7:013366. 

2.       Bas AY, Demirel N, Koc E, et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal in tensive care units. Br J Ophthalmol 2018;102:1711–16.

3.       Bas AY, Koc E, Dilmen U, ROP Neonatal Study Group. In cidence and severity of ROP in Turkey. Br J Ophthalmol 2015;99:1311–14.

4.       Coats DK. In Uptodate 2020: Retinopathy of prematurity: Pathogenesis, epidemiology, classification, and screening. https://www.uptodate.com/contents/retinopathy-of-pre maturity-pathogenesis-epidemiology-classification-and-sc reening.

5.       Fierson W, American Academy Of Pediatrics Section On Ophthalmology, American Academy Of Ophthalmology, American Associatıon For Pediatric Ophthalmology And Strabismus, American Associatıon Of Certıfıed Orthoptists. Screening examination of premature ınfants for retinopathy of prematurity. Pediatrics 2018 Dec;142(6):20183061. doi: 10.1542/peds.2018-3061.

6.       Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implicati ons for control. Early Hum Dev 2008;84 :77–82.

7.       Kaushal M, Razak A, Patel W, et al. Neurodevelopmental out comes following bevacizumab treatment for retinopathy of prematurity: A systematic review and meta-analysis. J Peri natol. 2021;41:1225-35.

8.       Marsh VA, Young WO, Dunaway KK, et al. Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother 2005;39:829 33.

9.       Mitchell A, Stevens B, Mungan N, et al. Analgesic effects of oral sucrose and pacifier during eye examinations for retinopathy of prematurity. Pain Manag Nurs 26.

10.   Morin J, Luu TM, Superstein R, et al. Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network In vestigators. Neurodevelopmental outcomes following beva cizumab injections for retinopathy of prematurity. Pediatrics 2016 Apr;137(4):20153218. doi: 10.1542/peds.2015-3218.

11.    Pia Lundqvist, Källén K, Hallström, et al. Trends in out comes for very preterm infants in the southern region of Swe den over a 10-year period. Acta Paediatr. 2009;98:648-53.

12.   Sun Y, Hellström A, Smith Lois E.H. Retinopathy of prematu rity. Fanaroff and Martin’s Neonatal Perinatal Medicine- Di seases of the Fetus and Newborn, 10th ed. Martin RJ, Fana roff AA, Walsh MC (eds): Saunders Elsevier, 2015;1767-74.

13.   UK Retinopathy of Prematurity Guideline, Royal Collage of Pa ediatrics and Child Health; Royal Collage of Ophthalmologists; British Association of Perinatal Medicine and BLISS, 2008.